To achieve adequate drug concentrations at the onset and throughout the operative procedure the initial dose must be given intravenously in the immediate pre-operative period (within 60 minutes for most antibiotics; 120 minutes for vancomycin and fluoroquinolones).
If surgery is longer than 4-6 hours a second intra-operative dose is advisable for some antibiotic regimens. (ceFAZolin: re-dose at 4 hours intra-op; clindamycin: re-dose at 6 hours intra-op; metroNIDAZOLE: re-dose at 8 hours intra-op; vancomycin: re-dose at 12 hours intra-op).
A single dose of preoperative antibiotics is sufficient for most surgical procedures. In general, post-operative doses should not exceed 24 hours.
Surgical Specialty | Patient Selection | Antibiotic Regimens | ||
---|---|---|---|---|
Recommended Regimen | Anaphylaxis to β-lactams | MRSA Positive | ||
General Surgery | Laparoscopic cholecystectomy
|
ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
Biliary, pancreas, liver | ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
|
Colorectal surgery | ceFAZolin* 2 g IV + metroNIDAZOLE 500 mg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV |
|
Appendectomy | ceFAZolin* 2 g IV + metroNIDAZOLE 500 mg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV |
|
Gastroduodenal/esophageal (including bariatric) | ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
|
Anorectal procedures
|
None required | None required | None required | |
Gynecological and Obstetric | Emergency or elective C-section | ceFAZolin* 2 g IV pre-op | clindamycin 900 mg IV + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
Hysterectomy or surgery for pelvic organ prolapse/stress urinary incontinence surgery | ceFAZolin* 2 g IV pre-op | clindamycin 900 mg IV pre-op + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV pre-op + tobramycin‡ 5 mg/kg IV pre-op |
|
Head and Neck Surgery, Plastic Surgery | Breast, thyroid, parathyroid | ceFAZolin* 2 g IV pre-op | vancomycin 15 mg/kg IV pre-op | vancomycin† 15 mg/kg IV pre-op |
Head and neck surgery involving incision of oral, pharyngeal or nasal mucosa | ceFAZolin* 2 g IV pre-op | clindamycin 900 mg IV pre-op | vancomycin 15 mg/kg IV + metroNIDAZOLE 500 mg IV pre-op |
|
Minor plastic surgery or no incision of mucosa | None required | None required | None required | |
Ocular surgery | Eye drops pre-op as per protocol | Eyedrops pre-op as per protocol | Eyedrops pre-op as per protocol | |
Orthopedic | Total joint replacement, hip fracture | ceFAZolin* 2 g IV pre-op and then 1g IV q8h x 24h post-op |
vancomycin† 15 mg/kg IV pre-op and then q12h x 24 h post-op§ | vancomycin† 15 mg/kg IV pre-op and then q12h x 24 h post-op§ |
Thoracic/ Vascular/ Pacemaker¶ | All except carotid or brachial | ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV pre-op | vancomycin† 15 mg/kg IV pre-op |
Urology# | Lower Tract | |||
Cystoscopy with manipulation | ceFAZolin* 2 g IV pre-op | ciprofloxacin 400 mg IV or 500 mg PO pre-op |
N/A as no skin breach | |
Transrectal ultrasound (TRUS) with prostate biopsy | ciprofloxacin 400 mg IV or 500 mg PO pre-op |
ciprofloxacin 400 mg IV or 500 mg PO pre-op |
N/A as no skin breach | |
Upper Tract | ||||
Shock wave lithotripsy or ureteroscopy¥ | ceFAZolin* 2 g IV pre-op | ciprofloxacin 400 mg IV or ciprofloxacin 500 mg PO pre-op |
N/A as no skin breach | |
Open or Laparoscopic | ||||
Not entering GU or GI tract (e.g. radical nephrectomy, laparoscopic nephrectomy) |
ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV pre-op | vancomycin† 15 mg/kg IV pre-op | |
Entering GU tract (e.g. radical prostatectomy) |
ceFAZolin* 2 g IV pre-op | vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV pre-op |
|
Entering GU and GI tract (e.g. radical cystectomy with ileoconduit, ileoconduit construction) |
ceFAZolin* 2 g IV pre-op + metroNIDAZOLE 500 mg IV pre-op |
vancomycin† 15 mg/kg IV + + |
vancomycin† 15 mg/kg IV + tobramycin‡ 5 mg/kg IV + metroNIDAZOLE 500 mg IV pre-op |
* If patient weight ≥120kg, use ceFAZolin 3 IV pre-op.
† Vancomycin dosing is based on actual body weight.
‡ Tobramycin dosing based on Ideal Body Weight (IBW) or Adjusted Body Weight (AdjBW) if weight is greater than 20% of IBW [AdjBW = IBW + 0.4 × (actual body weight - IBW)].
§ Dosing depends on renal function.
¶ Prophylaxis should be provided for all pacemaker insertions.
# Prophylaxis should be targeted to preoperative urinary cultures. For assistance with prophylaxis for resistant organisms, consult Infectious Diseases.
¥ If high risk features: immunosuppression, > 70 years of age, diabetes mellitus, active infection/infected stone/obstructive pyelonephritis.
Bratzler DW. Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-15.
American Academy of Orthopaedic Surgeons Advisory statement – Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty.
American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. 2001.
Society of Obstetrics and Gynecology of Canada (SOGC). Antibiotic Prophylaxis is Obstetric Procedures. 2010.
American Urological Association. Best Practice Policy Statement on Urological Surgery Antimicrobial Prophylaxis, updated 2008.
Best Practices in General Surgery. Strategies to prevent Surgical Site Infections. June 2012
Bratzler DW et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm 2013;70:195-283.